Company Page - COMPETITIVE TECHNOLOGIES INC

1375 Kings Highway	Research Report	Earnings Snapshot - Last 11/21/18
Fairfield, CT 06824	Fact Sheet
Phone: (203) 368-6044	Financial Statements
	Peer Comparison
	Annual Reports

Peter Brennan, Chmn., Carl O'Connell, CEO, Johnnie D. Johnson, CFO
CTTC is the licensed worldwide distributor of the non-invasive Calmare(R) pain therapy medical device, which incorporates the biophysical "Scrambler Therapy(TM)" technology developed in Italy by CTTC's client, Professor Giuseppe Marineo to treat neuropathic pain, including cancer pain. The Calmare(R) device is manufactured for sale by CTTC's partner, GEOMC Co., Ltd. of Seoul, Korea. Focus is identifying, developing and commercializing innovative products and technologies in life, electronic, nano, and physical sciences developed by universities, companies and inventors. Transfer to (OTCBB:CTTC) and new management team September 3, 2010. Established in 1968.

Historical Charts Technical Analysis

No Historical Data available for CTTC

Type of Stock Symbol Last Sale Last Close Net +/- % +/- Low High Volume 52wk Low 52wk High Shares(M)

Common CTTC $.145 $ 0 $.14 $.1453 15,500 $.13 $.8 14,467

Capitalization
Earnings Summary ()
*** No Earnings Available***
-10121

Common Stock $2,098

Split, Dividend and Symbol Change Information

Date Symbol Transaction Dividend Split New Symbol

13-JUN-11 CTT Symbol Changed to CTTC

Date	Symbol	Transaction	Dividend	Split	New Symbol
13-JUN-11	CTT	Symbol Changed to			CTTC

A373

QUICK NAVIGATION			SITE SEARCH Enter Keyword:

Home Subscribe Browser Help Subscriber Services B-to-B Banks Brokerage Telco Site Map Legal Contact/Email
Copyright © 1996 - 2024 Stock Smart with all rights reserved
Feed is currently being brought back up
Provided by Nanex